Unicycive Therapeutics, Inc., a clinical-stage biotechnology company focused on developing therapies for kidney diseases, unveiled its financial results for the quarter ending September 30, 2024.
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) commends the American College of Rheumatology (ACR) for their 2024 evidence-based guidelines for the screening, treatment, and management of lupus ...
Medtronic plc today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024. Key Highlights Revenue of $8.4 billion increased 5.3% as reported ...